DiscGenics, Inc.

Industry

  • Pharmaceuticals
  • Medical Devices
    • Biomaterials
  • Biotechnology
    • Gene Therapy, Cell Therapy
See more in Biomedtracker

Latest on DiscGenics, Inc.

Pink Sheet

US FDA’s Breakthrough Designation Pace Slows, But Topics Broaden

 
• By Bridget Silverman

US FDA’s flagship expedited review programs – the breakthrough therapy designation and its younger cousin, the biologics-focused regenerative medicine advanced therapy designation – have added new des

Scrip

Venture Funding Deals: Spin-Offs Gain Their Own Footing

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar

Scrip

Finance Watch: Genocea, Mateon Shift Strategies, Cut Jobs To Preserve Cash

 
• By Mandy Jackson

Investors apparently aren't as enthusiastic about Genocea Biosciences Inc. 's neoantigen-focused cancer vaccine program as its CEO is, because the company's stock plunged after it revealed plans to